Is COVID Making a Come-Back With Rising Case-Count?


Omicron’s highly contagious subvariant BA.2.12.1 is currently responsible for the majority of new COVID-19 cases in the United States. The subvariant, together with BA.2, is responsible for almost 101,000 new cases every day during the last week. While COVID-19-related mortality is decreasing, hospitalizations are increasing.

An increase in instances has resulted in an increasing number of patients experiencing lasting symptoms for months to more than a year following a COVID-19 infection. According to a study published on May 27 by the Centers for Disease Control and Prevention, one in every five people aged 18 to 64 years sustained protracted COVID following an acute COVID-19 infection. This ratio is one in four among the elderly.

With $2.2 billion in funding across 131 agreements in 2021 and an industry expected to be worth $50 billion by 2033, we are only seeing the tip of the iceberg. Global comparisons show that India’s health tech innovation has a lot of space to develop.

Long COVID is projected to be much less prevalent among children. Parents with children under the age of five, on the other hand, are anxious because no COVID-19 immunization has been approved for them. According to Ashish Jha, the White House’s new COVID-19 Response Coordinator, at a press briefing yesterday, the Food and Drug Administration will meet soon to consider low-dose Pfizer and Moderna COVID-19 vaccines for this age range.

“We’ve been working incredibly closely with states, local health departments, pediatricians, family physicians, other healthcare practitioners, and pharmacists to get ready,” he said. “We predict that the vast majority of these youngsters will be vaccinated by their primary care providers.”

The initial emphasis will be on high-priority locations, such as those that serve the most vulnerable children and are in remote areas. Children’s hospitals, which can handle large doses of vaccines, would also be favored.

However, the wave is generally traveling through countries as intended. When we look at the timing from the first major increase in reported cases to the peak in reported cases, we find that it varies by country and spans around 20-25 days. What’s more, regardless of the background level of immunization and previous infection, the time from introduction to peak appears to be quite consistent and appears to be about the same in very disparate places – in Canada, many states in the US, some northern states in Mexico, and countries like Qatar, Argentina, several countries in southern Europe, most of eastern and southern Africa, and some states in India.

So, in our opinion, Omicron is so transmissible that it reaches all of those who are still vulnerable, either due to decreased immunity from vaccination or previous infection, and then peaks and decreases. That hasn’t happened in previous rounds because of behavioral changes and government action – we haven’t seen all of the susceptible individuals become ill. This merely goes to show how fast and transmissible the Omicron wave is.

One advantage of COVID is that it has made people more aware of their health, which has expedited the development of telemedicine. During the COVID era, Remassis handled more than 25,000. “Approximately 25% of these conversations were from folks who just wanted to understand how to build stronger immunity and resistance to COVID-like viruses,” said Arunabh Sinha, co-founder of Remassis, a fast-growing cloud clinic, and telemedicine firm.

The government’s introduction of the Unified Health Interface (UHI) along the lines of UPI will be a big push in this direction. The National Digital Health Mission (NDHM) hopes that UHI would alter the healthcare system, making it more accessible and fordable while also preserving the protection of citizens’ personal health-related information.

While the success of UHI has yet to be shown, the earlier adoption of UPI in the finance area provides favorable precedence. UHI, when combined with the software prowess of India’s entrepreneurs’ startups, might achieve wonders for the country’s healthcare industry’s digitization.

Thus, with a population that is more conscious of preventative care, nutrition, and well-being, as well as concerned about rising healthcare costs and the incidence of chronic diseases, the expansion of HealthTech innovation is unavoidable.

COVID waves: What causes a spike in coronavirus cases?

Several factors have influenced whether new COVID-19 cases are increasing or decreasing in specific locations so far during the pandemic. These factors include vaccine effectiveness over time, human behavior, infection control measures, changes to the coronavirus itself, and the number of persons who are vulnerable due to a lack of immunity, whether from natural infection or vaccination.

Following COVID-19 measures, such as getting vaccinated for the coronavirus, practicing physical separation, hand-washing, and mask-wearing, helps to reduce viral transmission. Cases are more common in locations where:

Because fewer people are vaccinated, a huge number of people are vulnerable to infection.

Masks are being worn by fewer people.

More people are congregating indoors to eat, drink, celebrate, and socialize without being physically separated.

Furthermore, settings where people live or work closely together (multigenerational households, long-term-care institutions, jails, and some types of companies) are likely to see increased coronavirus spread.

Next Post

StatLab Medical Products acquires CellPath Ltd.

StatLab Medical Products (StatLab), an Audax Private Equity and Linden Capital Partners portfolio company and a leading developer and manufacturer of medical diagnostic supplies and equipment, today announced that it has acquired CellPath Ltd. (CellPath), a UK-based manufacturer and supplier of products and services focused on the histology and cytology markets. […]